125 related articles for article (PubMed ID: 37311352)
21. The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.
Yeshurun M; Weisdorf D; Rowe JM; Tallman MS; Zhang MJ; Wang HL; Saber W; de Lima M; Sandmaier BM; Uy G; Kamble RT; Cairo MS; Cooper BW; Cahn JY; Ganguly S; Camitta B; Verdonck LF; Dandoy C; Diaz MA; Savani BN; George B; Liesveld J; McGuirk J; Byrne M; Grunwald MR; Drobyski WR; Pulsipher MA; Abdel-Azim H; Prestidge T; Wieduwilt MJ; Martino R; Norkin M; Beitinjaneh A; Seo S; Nishihori T; Wirk B; Frangoul H; Bashey A; Mori S; Marks DI; Bachanova V
Blood Adv; 2019 Feb; 3(4):670-680. PubMed ID: 30808685
[TBL] [Abstract][Full Text] [Related]
22. Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Servais S; Beguin Y; Delens L; Ehx G; Fransolet G; Hannon M; Willems E; Humblet-Baron S; Belle L; Baron F
Expert Opin Investig Drugs; 2016 Aug; 25(8):957-72. PubMed ID: 27110922
[TBL] [Abstract][Full Text] [Related]
23. [Immune tolerance induced by cytokines in allogeneic hematopoietic stem cell transplantation].
Chang YJ; Huang XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 41(2):208-11. PubMed ID: 19377632
[TBL] [Abstract][Full Text] [Related]
24. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
[TBL] [Abstract][Full Text] [Related]
25. Ex Vivo CD34
Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
[TBL] [Abstract][Full Text] [Related]
26. [The Relationship between Occurrence of aGVHD in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation and Immune Cell Components in Graft].
Liu S; Zhou Z; Zhai WJ; Song XN; Li Q; Jiang EL; Feng SZ; Sun JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):539-545. PubMed ID: 37096531
[TBL] [Abstract][Full Text] [Related]
27. The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment.
Shang T; Guo Y; Li XR; Zhou Z; Qi Y; Salahdiin K; Shen R; He S; Wang M; Shi ZX; Zhao X; Yang J; Fan G; Wang Y; Gao X; Zhu Y; Feng Y
Biomed Pharmacother; 2022 Apr; 148():112675. PubMed ID: 35183993
[TBL] [Abstract][Full Text] [Related]
28. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
[TBL] [Abstract][Full Text] [Related]
29. Suppression of Hematopoietic Primitive Cells in Patients with Secondary Failure of Platelet Recovery after Acute Graft-versus-Host Disease.
Huang A; Zhao X; Li M; Tang G; Fei Y; Wang R; Gao L; Ni X; Zhang W; Yang J; Hu X; Wang J
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1840-1854. PubMed ID: 32534102
[TBL] [Abstract][Full Text] [Related]
30. [Clinical study on the relapsd leukemia patients with graft versus host disease after allogeneic hematopoietic stem cell transplantation].
Zhang XH; Fu HX; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Zhao T; Wang Y; Chen Y; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2010 May; 31(5):323-7. PubMed ID: 21122312
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of IL-1 Receptor-Associated Kinase 1 Decreases Murine Acute Graft-versus-Host Disease While Preserving the Graft-versus-Lymphoma Effect.
Gao J; Xu Y; Ma S; Liang Y; Liu C; Shen J; Sun Z; Niu M; Xu K; Pan B
Transplant Cell Ther; 2022 Mar; 28(3):134.e1-134.e10. PubMed ID: 34896653
[TBL] [Abstract][Full Text] [Related]
32. Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Vignon M; Andreoli A; Dhédin N; Lengliné E; Masson E; Robin M; Granier C; Larghero J; Schlageter MH; de Latour RP; Socié G; Boissel N
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):299-306. PubMed ID: 27983886
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease.
Le HT; Keslar K; Nguyen QT; Blazar BR; Hamilton BK; Min B
Front Immunol; 2020; 11():181. PubMed ID: 32117306
[TBL] [Abstract][Full Text] [Related]
34. TGF-beta in allogeneic stem cell transplantation: friend or foe?
Banovic T; MacDonald KP; Morris ES; Rowe V; Kuns R; Don A; Kelly J; Ledbetter S; Clouston AD; Hill GR
Blood; 2005 Sep; 106(6):2206-14. PubMed ID: 15941908
[TBL] [Abstract][Full Text] [Related]
35. hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype.
Su Y; Sun X; Liu X; Qu Q; Yang L; Chen Q; Liu F; Li Y; Wang Q; Huang B; Huang XJ; Zhang XH
J Hematol Oncol; 2022 Jul; 15(1):99. PubMed ID: 35864538
[TBL] [Abstract][Full Text] [Related]
36. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
37. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
[TBL] [Abstract][Full Text] [Related]
38. [Effect of graft-versus-host disease on relapse and survival in 100 patients after allogeneic hematopoietic stem cell transplantation].
Deng XR; Ren HY; Cen XN; Wang LH; Liang ZY; Wang WS; Qiu ZX; Ou JP; Xu WL; Wang MJ; Li Y; Yin Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):994-8. PubMed ID: 19698246
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Bianchi M; Heim D; Lengerke C; Halter J; Gerull S; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Ann Hematol; 2019 Apr; 98(4):971-977. PubMed ID: 30542943
[TBL] [Abstract][Full Text] [Related]
40. PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.
Lee SH; Moon SJ; Park MJ; Kim EK; Moon YM; Cho ML
Immunol Lett; 2014 Jul; 160(1):79-88. PubMed ID: 24718277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
